西藏自治区妇女子宫颈人乳头状瘤病毒感染现状调查及相关因素分析

靳琼, 沈铿, 李辉, 周先荣, 黄惠芳, 冷金花, 章文华… - 中华妇产科杂志, 2009 - cqvip.com
目的了解我国西藏自治区妇女宫颈人乳头状瘤病毒(HPV) 感染率和亚型分布及与HPV
感染相关的因素. 方法于2007 年8 月, 采用整群抽样的方法对西藏自治区拉萨, 日喀则和那曲3 …

Vaccination trial with HPV16 L1E7 chimeric virus‐like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)

AM Kaufmann, JD Nieland, I Jochmus… - … journal of cancer, 2007 - Wiley Online Library
Persistent infection with human papillomaviruses (HPV) is a prerequisite for the
development of cervical cancer. Vaccination with virus‐like particles (VLP) has …

Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India

S Pande, N Jain, BK Prusty, S Bhambhani… - Journal of clinical …, 2008 - Am Soc Microbiol
High-risk human papillomaviruses (HPVs), particularly HPV types 16 and 18 (HPV-16 and
HPV-18, respectively), play a cardinal role in the etiology of cervical cancer. The most …

[HTML][HTML] Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women

K Aro, P Nieminen, K Louvanto, M Jakobsson… - Gynecologic …, 2019 - Elsevier
Background and aim Age-specific type-distribution of high-risk human papillomavirus
(hrHPV) in cervical precancerous lesions is subject to change in the HPV vaccination era …

Clinical utility of HPV genotyping

CJ Meijer, PJ Snijders… - Gynecologic …, 2006 - gynecologiconcology-online.net
Cervical cancer screening is presently done by finding abnormal cells in cervical smears (ie,
cervical cytology or Pap smears). However, cervical cytology is not full-proof. Cervical …

[HTML][HTML] HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future

L Mariani, A Venuti - Journal of translational medicine, 2010 - Springer
Although long-term protection is a key-point in evaluating HPV-vaccine over time, there is
currently inadequate information on the duration of HPV vaccine-induced immunity and on …

Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing

M Schiffman - … International Journal of the American Cancer …, 2007 - Wiley Online Library
There is justifiable excitement about the recent introduction of prophylactic vaccines against
human papillomavirus (HPV) types 16 (HPV‐16) and HPV‐18. Preventing these infections …

[HTML][HTML] Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study

J Ye, X Cheng, X Chen, F Ye, W Lü, X Xie - Virology journal, 2010 - Springer
Background Benign or malignant lesions caused by Human papillomavirus (HPV) produce
considerable health burden worldwide. Since limited cross-protection would be offered …

Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon nature

TF Schwarz, O Leo - Gynecologic oncology, 2008 - Elsevier
An AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine has demonstrated
excellent efficacy for up to 6.4 years in preventing related persistent infections and cervical …

Human papilloma virus vaccination: impact and recommendations across the world

P Bonanni, A Bechini, R Donato… - Therapeutic …, 2015 - journals.sagepub.com
Human papilloma virus (HPV) vaccination has been implemented in several countries for
about the past 7 years, mainly in the adolescent female population, with varying coverage …